Loraz and Jublia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Jublia (efinaconazole). Common drug interactions include chills among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Jublia. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Jublia?

Jublia has active ingredients of efinaconazole. eHealthMe is studying from 1,780 Jublia users. Check the latest studies of Jublia.

On Jul, 17, 2026

56 people who take Loraz and Jublia together, and have interactions are studied.

What are the common drug interactions of Loraz and Jublia, by gender? *:

female:

Chills (felling of cold)
Decreased appetite
Disability
Drug ineffective
Dry eye (lack of adequate tears)
Dry mouth
Dry skin
Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers)
Emotional disorder
Endocarditis (inflammation in heart muscle)

male:

Febrile neutropenia (fever with reduced white blood cells)
Back disorder
Osteomyelitis (infection of bone)
Rash erythematous (redness of the skin)
Procedural pain
Suicide attempt
Abdominal discomfort
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Emotional distress
Hypertension (high blood pressure)

What are the common drug interactions of Loraz and Jublia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Febrile neutropenia (fever with reduced white blood cells)

50-59:

Nausea (feeling of having an urge to vomit)
Abdominal pain
Asthenia (weakness)
Dehydration (dryness resulting from the removal of water)
Lactic acidosis (low ph in body tissues)
Metabolic alkalosis (too much bicarbonate in the blood)
Renal failure (kidney dysfunction)
Vomiting
Back disorder
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

60+:

Infusion site erythema (reddening of the skin at infusion site)
Injection site pain
Cough
Drug ineffective
Dry eye (lack of adequate tears)
Dry skin
Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers)
Dyspnoea (difficult or laboured respiration)
Emotional disorder
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Type 2 Diabetes: 16 people, 28.57%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 15 people, 26.79%
Insomnia (sleeplessness): 9 people, 16.07%
Burkitt's Lymphoma Stage Iv (blood cancer stage iv): 6 people, 10.71%
Burkitt's Lymphoma (cancer of the lymphatic system): 5 people, 8.93%
Multiple Myeloma (cancer of the plasma cells): 3 people, 5.36%
High Blood Pressure: 3 people, 5.36%
Fungal Nail Infection: 3 people, 5.36%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Jublia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously